U.S. Bancorp USB has been analyzed by 14 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 8 | 6 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 4 | 4 | 0 | 0 |
2M Ago | 0 | 2 | 1 | 0 | 0 |
3M Ago | 0 | 1 | 1 | 0 | 0 |
Analysts have recently evaluated U.S. Bancorp and provided 12-month price targets. The average target is $55.14, accompanied by a high estimate of $64.00 and a low estimate of $46.00. This current average reflects an increase of 5.31% from the previous average price target of $52.36.
Investigating Analyst Ratings: An Elaborate Study
A comprehensive examination of how financial experts perceive U.S. Bancorp is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Mike Mayo | Wells Fargo | Raises | Overweight | $62.00 | $60.00 |
Chris Kotowski | Oppenheimer | Raises | Outperform | $64.00 | $59.00 |
Vijay Kumar | Evercore ISI Group | Raises | In-Line | $54.00 | $51.00 |
Matt O'Connor | Deutsche Bank | Maintains | Hold | $51.00 | $51.00 |
Peter Winter | DA Davidson | Raises | Neutral | $54.00 | $49.00 |
Mike Mayo | Wells Fargo | Raises | Overweight | $60.00 | $52.00 |
Jason Goldberg | Barclays | Raises | Overweight | $57.00 | $52.00 |
Chris Kotowski | Oppenheimer | Raises | Outperform | $59.00 | $57.00 |
Terry McEvoy | Stephens & Co. | Raises | Equal-Weight | $52.00 | $49.00 |
Vijay Kumar | Evercore ISI Group | Raises | In-Line | $51.00 | $49.00 |
Chris Kotowski | Oppenheimer | Raises | Outperform | $57.00 | $54.00 |
Betsy Graseck | Morgan Stanley | Raises | Overweight | $57.00 | $54.00 |
Gerard Cassidy | RBC Capital | Maintains | Outperform | $48.00 | $48.00 |
Richard Ramsden | Goldman Sachs | Lowers | Neutral | $46.00 | $48.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to U.S. Bancorp. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of U.S. Bancorp compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of U.S. Bancorp's stock. This analysis reveals shifts in analysts' expectations over time.
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of U.S. Bancorp's market position. Stay informed and make well-informed decisions with our Ratings Table.
Stay up to date on U.S. Bancorp analyst ratings.
Delving into U.S. Bancorp's Background
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in roughly 26 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
U.S. Bancorp: Financial Performance Dissected
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, U.S. Bancorp faced challenges, resulting in a decline of approximately -2.39% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: U.S. Bancorp's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 23.43%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): U.S. Bancorp's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 3.15%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): U.S. Bancorp's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.23%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.51.
How Are Analyst Ratings Determined?
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.